We are pleased to announce the commercialization of “N-NOSE plus Pancreas”, the world’s first cancer type specific test, the next generation of the N-NOSE nematode cancer test.
“N-NOSE plus Pancreas”, the world’s first test to detect early-stage pancreatic cancer, is now available for practical use.
HIROTSU Bio Science Inc. (Head Office: Chiyoda-ku, Tokyo; Representative: Takaaki Hirotsu (Hereinafter referred to as “HIROTSU”)) has joined "UB . . .2023.10.18
－Pre-orders available today, special pricing offers for pre-applicants－ HIROTSU Bio Science Inc. (Head Office: Chiyoda-ku, Tokyo; Represent . . .2023.10.13
HIROTSU BIO SCIENCE Corporation is proud to announce the opening of a store on Tmall Global, the largest cross-border EC platform in China opera . . .2023.08.22